Renowned Hindi and Marathi actress Pravina Deshpande passed away at 60 after battling multiple myeloma since 2019. Known for Ghar Ek Mandir, Kumkum, and films like Ready, she faced skin eruptions, ...
The FDA has started a priority review of iberdomide as an add-on to Johnson & Johnson and Genmab's anti-CD38 antibody Darzalex (daratumumab) and dexamethasone, a standard regimen for relapsed or ...
Onlymyhealth on MSN
Marathi Actress Pravina Deshpande, Salman Khan’s ‘Ready’ Co-Star, Dies After Long Battle With Cancer
Veteran Marathi and Hindi film and television actress Pravina Deshpande, best known for her role in Salman Khan’s 2011 film ...
Bristol Myers Squibb said the U.S. Food and Drug Administration has granted priority review to its application seeking approval of its iberdomide drug candidate in certain patients with the blood ...
Veteran Marathi and Hindi film actress Pravina Deshpande died on February 17, 2026, at age 60 due to complications caused by ...
Doctors at Boston’s Beth Israel share how CAR T cell therapy and other emerging immune therapies are delivering promising ...
NDTV Profit on MSN
'Ready' Actor Pravina Deshpande Passes Away At 60 After Cancer Battle
Pravina Deshpande had been undergoing treatment for multiple myeloma, a form of blood cancer, since 2019 ...
After a broken femur led to a multiple myeloma diagnosis, one patient is raising awareness while specialists point to new treatment options and early detection.
Veteran actress Pravina Deshpande passed away on February 17, 2026, at 60 after a long battle with multiple myeloma.
At Beth Israel Deaconess Medical Center, doctors say a once-fringe treatment for multiple myeloma is starting to look like a legitimate frontline weapon for some patients. CAR T cell therapy is ...
Pravina Deshpande was an Indian actress known for her work in Marathi and Hindi films, television shows, and theatre. She gained recognition through popular TV serials and notable film roles, and was ...
Study expected to enroll 24 patients with the option to enroll an additional 45 patients at the recommended Phase 2 doseProtocol calls for three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results